Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
86073 participants
OBSERVATIONAL
2010-01-01
2018-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Results of Pancreatic Operations After the Implementation of Multidisciplinary Team Conference (MDT):
NCT04237441
Survival Among Patients With Pancreatic Cancer Depending on Surgical Resection Rate
NCT04802993
Pancreatic Surgery in Elderly Patients
NCT04893408
Predictors for Low Rates of Surgical Resection in Elderly Patients With Resectable Pancreatic Ductal Adenocarcinoma
NCT06344299
Laparoscopic vs Open Pancreatectomy for Body and Tail Pancreatic Cancer
NCT03792932
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients treated in high-volume pancreatic centers
Patients treated at a hospital performing at least 50 pancreatic resection procedures annually during 2010 to 2018
Persons with pancreatic resection in a hospital with at least 50 pancreatic resections annually (observational),
Persons that have undergone a pancreatic resection at a hospital with at least 50 pancreatic resections annually (observational)
Patients treated in low-volume pancreatic centers
Patients not treated at a hospital performing at least 50 pancreatic resection procedures annually during 2010 to 2018
Persons with pancreatic resection in a hospital not performing at least 50 pancreatic resections annually (observational),
Persons that have undergone a pancreatic resection at a hospital with not at least 50 pancreatic resections annually (observational)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Persons with pancreatic resection in a hospital with at least 50 pancreatic resections annually (observational),
Persons that have undergone a pancreatic resection at a hospital with at least 50 pancreatic resections annually (observational)
Persons with pancreatic resection in a hospital not performing at least 50 pancreatic resections annually (observational),
Persons that have undergone a pancreatic resection at a hospital with not at least 50 pancreatic resections annually (observational)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* subjects with a pancreatic transplantation procedure
* missing information on age or gender
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medizinische Hochschule Brandenburg Theodor Fontane
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rene Mantke
Head of Surgery
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rene Mantke, MD, PhD
Role: STUDY_DIRECTOR
Head of Surgery at University Hospital Brandenburg an der Havel
References
Explore related publications, articles, or registry entries linked to this study.
Mantke R, Seliger B, Ogino S, Buchler MW, Hunger R. Not Only Caseload but Also Patient Selection Is Predictive of Mortality After Pancreatic Resection. Ann Surg Open. 2024 Dec 30;6(1):e536. doi: 10.1097/AS9.0000000000000536. eCollection 2025 Mar.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PatSelPanc
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.